EC Clinical Trials · July 07, 2025

Stakeholders' Consultation on EudraLex Volume 4 - Good Manufacturing Practice Guidelines: Chapter 4, Annex 11 and New Annex 22

Original title: Stakeholders’ Consultation on EudraLex Volume 4 - Good Manufacturing Practice Guidelines: Chapter 4, Annex 11 and New Annex 22

Public consultation opened on amendments to GMP guidelines covering manufacturing controls, computerised systems, and new requirements for advanced therapy medicinal products.

Medium impact Pharmaceuticals Clinical Trials & Research EU-wide pharmaceuticals

News announcement 7 July 2025 Stakeholders’ Consultation on EudraLex Volume 4 - Good Manufacturing Practice Guidelines: Chapter 4, Annex 11 and New Annex 22 1 min read

Read the official source ↗

Published by EC Clinical Trials. HealthSignal links to the original document; the summary above is extracted from the source text.